Research Triangle Park, North Carolina based BioMarck Pharmaceuticals was granted a United States Patent No. 8,293,870 for its proprietary peptide BIO-11006 for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
(PRWeb November 14, 2012)
Read the full story at http://www.prweb.com/releases/2012/11/prweb10134283.htm
